

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 6.71433876 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.46241471 |
| 3 | viral transcription (GO:0019083) | 6.29531059 |
| 4 | translational termination (GO:0006415) | 6.16000767 |
| 5 | maturation of SSU-rRNA (GO:0030490) | 5.97551775 |
| 6 | ribosomal large subunit biogenesis (GO:0042273) | 5.43028778 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.39562349 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.31327631 |
| 9 | translational elongation (GO:0006414) | 5.30390820 |
| 10 | protein targeting to ER (GO:0045047) | 5.26965597 |
| 11 | DNA deamination (GO:0045006) | 5.08658553 |
| 12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.00962825 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 5.00144762 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 4.93474470 |
| 15 | translational initiation (GO:0006413) | 4.88842996 |
| 16 | cellular protein complex disassembly (GO:0043624) | 4.87453504 |
| 17 | viral life cycle (GO:0019058) | 4.82537947 |
| 18 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.82271319 |
| 19 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.68070442 |
| 20 | termination of RNA polymerase III transcription (GO:0006386) | 4.47115577 |
| 21 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.47115577 |
| 22 | 7-methylguanosine mRNA capping (GO:0006370) | 4.46990173 |
| 23 | proteasome assembly (GO:0043248) | 4.44866336 |
| 24 | 7-methylguanosine RNA capping (GO:0009452) | 4.41343450 |
| 25 | RNA capping (GO:0036260) | 4.41343450 |
| 26 | translation (GO:0006412) | 4.27268157 |
| 27 | protein complex disassembly (GO:0043241) | 4.22331033 |
| 28 | rRNA processing (GO:0006364) | 4.11868441 |
| 29 | protein complex biogenesis (GO:0070271) | 4.09664449 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.07191580 |
| 31 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 4.02314455 |
| 32 | respiratory electron transport chain (GO:0022904) | 4.01730499 |
| 33 | macromolecular complex disassembly (GO:0032984) | 4.00979567 |
| 34 | rRNA metabolic process (GO:0016072) | 3.98082061 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.97596693 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.95795803 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.95795803 |
| 38 | cellular component biogenesis (GO:0044085) | 3.94852017 |
| 39 | formation of translation preinitiation complex (GO:0001731) | 3.94404815 |
| 40 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.94186626 |
| 41 | electron transport chain (GO:0022900) | 3.92915191 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.91827461 |
| 43 | rRNA modification (GO:0000154) | 3.90602518 |
| 44 | * termination of RNA polymerase I transcription (GO:0006363) | 3.87579804 |
| 45 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.79440110 |
| 46 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.73225020 |
| 47 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.73126124 |
| 48 | GTP biosynthetic process (GO:0006183) | 3.71880965 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.70020877 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.68893429 |
| 51 | transcription from RNA polymerase I promoter (GO:0006360) | 3.67669607 |
| 52 | spliceosomal snRNP assembly (GO:0000387) | 3.64686062 |
| 53 | ribosome biogenesis (GO:0042254) | 3.64371827 |
| 54 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.62220749 |
| 55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.59260258 |
| 56 | negative regulation of ligase activity (GO:0051352) | 3.59260258 |
| 57 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.59082892 |
| 58 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.56394659 |
| 59 | mRNA catabolic process (GO:0006402) | 3.53876179 |
| 60 | protein targeting to mitochondrion (GO:0006626) | 3.53400868 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50642494 |
| 62 | ribosome assembly (GO:0042255) | 3.48200371 |
| 63 | DNA replication checkpoint (GO:0000076) | 3.47517205 |
| 64 | UTP biosynthetic process (GO:0006228) | 3.42356977 |
| 65 | protein targeting to membrane (GO:0006612) | 3.40875030 |
| 66 | pseudouridine synthesis (GO:0001522) | 3.40195888 |
| 67 | purine nucleobase biosynthetic process (GO:0009113) | 3.39327970 |
| 68 | DNA strand elongation (GO:0022616) | 3.39102011 |
| 69 | mitotic metaphase plate congression (GO:0007080) | 3.38812492 |
| 70 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.36199351 |
| 71 | telomere maintenance via recombination (GO:0000722) | 3.35644568 |
| 72 | respiratory chain complex IV assembly (GO:0008535) | 3.33786405 |
| 73 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.33294203 |
| 74 | positive regulation of viral transcription (GO:0050434) | 3.32905379 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.32272466 |
| 76 | RNA catabolic process (GO:0006401) | 3.32177635 |
| 77 | kinetochore assembly (GO:0051382) | 3.31951309 |
| 78 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.30359532 |
| 79 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30013527 |
| 80 | oxidative phosphorylation (GO:0006119) | 3.29454152 |
| 81 | establishment of integrated proviral latency (GO:0075713) | 3.29213001 |
| 82 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.29091997 |
| 83 | DNA replication initiation (GO:0006270) | 3.27782557 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.27212841 |
| 85 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.27212841 |
| 86 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.27211424 |
| 87 | establishment of protein localization to mitochondrion (GO:0072655) | 3.26865552 |
| 88 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.26796404 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.26796404 |
| 90 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.26796404 |
| 91 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.26579401 |
| 92 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.26532092 |
| 93 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.26365105 |
| 94 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.26365105 |
| 95 | protein localization to mitochondrion (GO:0070585) | 3.24135877 |
| 96 | spliceosomal complex assembly (GO:0000245) | 3.21393989 |
| 97 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.20081613 |
| 98 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.20081613 |
| 99 | DNA damage response, detection of DNA damage (GO:0042769) | 3.17759145 |
| 100 | nucleobase biosynthetic process (GO:0046112) | 3.17571869 |
| 101 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.16280816 |
| 102 | peptidyl-histidine modification (GO:0018202) | 3.15739562 |
| 103 | cytochrome complex assembly (GO:0017004) | 3.15068342 |
| 104 | CENP-A containing nucleosome assembly (GO:0034080) | 3.14502639 |
| 105 | positive regulation of ligase activity (GO:0051351) | 3.13676082 |
| 106 | rRNA methylation (GO:0031167) | 3.13465261 |
| 107 | DNA-templated transcription, elongation (GO:0006354) | 3.13178593 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12226312 |
| 109 | protein neddylation (GO:0045116) | 3.09230989 |
| 110 | ncRNA processing (GO:0034470) | 3.09060096 |
| 111 | kinetochore organization (GO:0051383) | 3.07801758 |
| 112 | regulation of mitochondrial translation (GO:0070129) | 3.06552972 |
| 113 | inner mitochondrial membrane organization (GO:0007007) | 3.06417305 |
| 114 | chromatin remodeling at centromere (GO:0031055) | 3.03704648 |
| 115 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.03596663 |
| 116 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.02432642 |
| 117 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.01434584 |
| 118 | NADH dehydrogenase complex assembly (GO:0010257) | 3.01434584 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.01434584 |
| 120 | CTP metabolic process (GO:0046036) | 3.00069267 |
| 121 | histone exchange (GO:0043486) | 2.96205594 |
| 122 | mitochondrial RNA metabolic process (GO:0000959) | 2.95278049 |
| 123 | ATP biosynthetic process (GO:0006754) | 2.89297588 |
| 124 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.88487267 |
| 125 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87227459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.99320888 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.53098409 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.48321052 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.14444130 |
| 5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.00665948 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.85292207 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.80670621 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.66288340 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.47198852 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.44993505 |
| 11 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.29946894 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.17654396 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.17186220 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.13188126 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.12579214 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.07976140 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.94326221 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.92223163 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83244585 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.79070038 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.75228635 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61360880 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57134825 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.52066000 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.43098808 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.26824232 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22875642 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19971775 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.16642113 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.15258348 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.11406021 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.10803337 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10459472 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.02757962 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01297854 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99675206 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91187755 |
| 38 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.86321214 |
| 39 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81185046 |
| 40 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.78128599 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.74436792 |
| 42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70219502 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69052649 |
| 44 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67777415 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67016860 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66708125 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62416989 |
| 48 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.61615197 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61558837 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61009205 |
| 51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54690482 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53712314 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53348283 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52209073 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46762621 |
| 56 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.45815771 |
| 57 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38228297 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33162147 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.29820160 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29650354 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28686598 |
| 62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28041156 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26150060 |
| 64 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.25526450 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23766480 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23459301 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22696207 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22418769 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21738203 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21565437 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17886985 |
| 72 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16714930 |
| 73 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.14614373 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06802412 |
| 75 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00851556 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98823074 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97447558 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96343392 |
| 79 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95240912 |
| 80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93412484 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91406697 |
| 82 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89178062 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88412510 |
| 84 | * HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.87682951 |
| 85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87479729 |
| 86 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87303835 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86533237 |
| 88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85310383 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84817465 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82494140 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82433473 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82397666 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81194956 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79025142 |
| 95 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77633601 |
| 96 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.77619357 |
| 97 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77332253 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76949024 |
| 99 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.75633479 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.75580206 |
| 101 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.75398796 |
| 102 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.75031933 |
| 103 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.74260073 |
| 104 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73212445 |
| 105 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.73037821 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.73012804 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72757575 |
| 108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72153514 |
| 109 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.70566572 |
| 110 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.69622880 |
| 111 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.69294675 |
| 112 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.69181569 |
| 113 | EWS_26573619_Chip-Seq_HEK293_Human | 0.67634051 |
| 114 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.66636720 |
| 115 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.65732720 |
| 116 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.63239370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.52124911 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.01393973 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.82940024 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.61059116 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.48456416 |
| 6 | MP0008058_abnormal_DNA_repair | 3.35886019 |
| 7 | MP0003077_abnormal_cell_cycle | 3.32399995 |
| 8 | MP0010094_abnormal_chromosome_stability | 3.30704217 |
| 9 | MP0008057_abnormal_DNA_replication | 3.10116214 |
| 10 | MP0003786_premature_aging | 2.92461472 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.56819120 |
| 12 | MP0004147_increased_porphyrin_level | 2.55724399 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.51681043 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.44957365 |
| 15 | MP0005410_abnormal_fertilization | 2.23043043 |
| 16 | MP0003718_maternal_effect | 2.14020687 |
| 17 | MP0003123_paternal_imprinting | 2.02303366 |
| 18 | MP0002938_white_spotting | 1.96371342 |
| 19 | MP0002132_abnormal_respiratory_system | 1.89889669 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.84823128 |
| 21 | MP0003315_abnormal_perineum_morphology | 1.76419260 |
| 22 | MP0008877_abnormal_DNA_methylation | 1.73309186 |
| 23 | MP0000490_abnormal_crypts_of | 1.73138497 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.71135948 |
| 25 | MP0002102_abnormal_ear_morphology | 1.65173259 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.64841576 |
| 27 | MP0005671_abnormal_response_to | 1.63273040 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.58870855 |
| 29 | MP0001873_stomach_inflammation | 1.56137097 |
| 30 | MP0001188_hyperpigmentation | 1.52198205 |
| 31 | MP0008995_early_reproductive_senescence | 1.51458610 |
| 32 | MP0003941_abnormal_skin_development | 1.51416907 |
| 33 | MP0001730_embryonic_growth_arrest | 1.47623710 |
| 34 | MP0005394_taste/olfaction_phenotype | 1.46782800 |
| 35 | MP0005499_abnormal_olfactory_system | 1.46782800 |
| 36 | MP0001764_abnormal_homeostasis | 1.46195494 |
| 37 | MP0003136_yellow_coat_color | 1.41302485 |
| 38 | MP0001529_abnormal_vocalization | 1.36850734 |
| 39 | MP0000350_abnormal_cell_proliferation | 1.35861380 |
| 40 | MP0001293_anophthalmia | 1.35172934 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.29547291 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.25287409 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.24795950 |
| 44 | MP0003698_abnormal_male_reproductive | 1.24672586 |
| 45 | MP0002398_abnormal_bone_marrow | 1.20087729 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.18657852 |
| 47 | MP0002722_abnormal_immune_system | 1.17748333 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.15608184 |
| 49 | MP0003186_abnormal_redox_activity | 1.15547930 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.13642499 |
| 51 | MP0002160_abnormal_reproductive_system | 1.13530416 |
| 52 | MP0000313_abnormal_cell_death | 1.12722983 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.12377622 |
| 54 | MP0001727_abnormal_embryo_implantation | 1.10881117 |
| 55 | MP0003878_abnormal_ear_physiology | 1.08338488 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.08338488 |
| 57 | MP0001853_heart_inflammation | 1.06841467 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.06693335 |
| 59 | MP0003011_delayed_dark_adaptation | 1.06020473 |
| 60 | MP0001697_abnormal_embryo_size | 1.05633529 |
| 61 | MP0002163_abnormal_gland_morphology | 1.01207632 |
| 62 | MP0002210_abnormal_sex_determination | 1.00422716 |
| 63 | MP0001905_abnormal_dopamine_level | 0.99397625 |
| 64 | MP0005389_reproductive_system_phenotype | 0.98898155 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.98701744 |
| 66 | MP0001800_abnormal_humoral_immune | 0.98571781 |
| 67 | MP0002080_prenatal_lethality | 0.98557640 |
| 68 | MP0005409_darkened_coat_color | 0.98312723 |
| 69 | MP0010307_abnormal_tumor_latency | 0.97604986 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.97018903 |
| 71 | MP0005380_embryogenesis_phenotype | 0.96488528 |
| 72 | MP0001672_abnormal_embryogenesis/_devel | 0.96488528 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.96343245 |
| 74 | MP0002429_abnormal_blood_cell | 0.95753130 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.95294015 |
| 76 | MP0001835_abnormal_antigen_presentation | 0.94836397 |
| 77 | MP0002420_abnormal_adaptive_immunity | 0.94221604 |
| 78 | MP0000716_abnormal_immune_system | 0.94017525 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 0.93823672 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.93712905 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 0.93712905 |
| 82 | MP0000358_abnormal_cell_content/ | 0.93104745 |
| 83 | MP0004381_abnormal_hair_follicle | 0.92803651 |
| 84 | MP0001819_abnormal_immune_cell | 0.91967699 |
| 85 | MP0003866_abnormal_defecation | 0.88431140 |
| 86 | MP0005253_abnormal_eye_physiology | 0.87842852 |
| 87 | MP0001145_abnormal_male_reproductive | 0.87055296 |
| 88 | MP0009785_altered_susceptibility_to | 0.86879423 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.85609184 |
| 90 | MP0008872_abnormal_physiological_respon | 0.85360766 |
| 91 | MP0002723_abnormal_immune_serum | 0.83935738 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.83725100 |
| 93 | MP0003938_abnormal_ear_development | 0.83281199 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.82583070 |
| 95 | MP0001919_abnormal_reproductive_system | 0.82232009 |
| 96 | MP0001929_abnormal_gametogenesis | 0.80962496 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80211125 |
| 98 | MP0000613_abnormal_salivary_gland | 0.79580720 |
| 99 | MP0002085_abnormal_embryonic_tissue | 0.79404975 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.79360942 |
| 101 | MP0000653_abnormal_sex_gland | 0.78710920 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.78624042 |
| 103 | MP0002161_abnormal_fertility/fecundity | 0.78352134 |
| 104 | MP0005395_other_phenotype | 0.78297940 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.77161209 |
| 106 | MP0000049_abnormal_middle_ear | 0.76226819 |
| 107 | MP0004133_heterotaxia | 0.76014869 |
| 108 | MP0003984_embryonic_growth_retardation | 0.75951905 |
| 109 | MP0001119_abnormal_female_reproductive | 0.75716937 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.74997018 |
| 111 | MP0009697_abnormal_copulation | 0.74890891 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.74626350 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.73525537 |
| 114 | MP0000685_abnormal_immune_system | 0.72961409 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72881587 |
| 116 | MP0002088_abnormal_embryonic_growth/wei | 0.72703842 |
| 117 | MP0005408_hypopigmentation | 0.72698567 |
| 118 | MP0001881_abnormal_mammary_gland | 0.71628144 |
| 119 | MP0002405_respiratory_system_inflammati | 0.70713710 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.70258752 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.70227535 |
| 122 | MP0000858_altered_metastatic_potential | 0.69807059 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.69723862 |
| 124 | MP0005000_abnormal_immune_tolerance | 0.69321619 |
| 125 | MP0005266_abnormal_metabolism | 0.68515135 |
| 126 | MP0005025_abnormal_response_to | 0.67822293 |
| 127 | MP0005310_abnormal_salivary_gland | 0.66930896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.23843406 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.51856864 |
| 3 | Reticulocytopenia (HP:0001896) | 5.12406690 |
| 4 | Macrocytic anemia (HP:0001972) | 4.26686485 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.12403549 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 3.94813321 |
| 7 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.94271916 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.94271916 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.70680936 |
| 10 | Pallor (HP:0000980) | 3.66541374 |
| 11 | Breast hypoplasia (HP:0003187) | 3.62023011 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.57243921 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.50104780 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.43634566 |
| 15 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.42117055 |
| 16 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.37506167 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 3.34170536 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.31144427 |
| 19 | Aplastic anemia (HP:0001915) | 3.24821157 |
| 20 | Increased CSF lactate (HP:0002490) | 3.23331653 |
| 21 | Hepatocellular necrosis (HP:0001404) | 3.16239841 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 3.09972602 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.06863186 |
| 24 | Microvesicular hepatic steatosis (HP:0001414) | 3.06339981 |
| 25 | Rough bone trabeculation (HP:0100670) | 2.94822477 |
| 26 | Exertional dyspnea (HP:0002875) | 2.92633157 |
| 27 | Acute encephalopathy (HP:0006846) | 2.92366073 |
| 28 | Oral leukoplakia (HP:0002745) | 2.90991193 |
| 29 | Increased serum lactate (HP:0002151) | 2.78271733 |
| 30 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.74923950 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 2.74331512 |
| 32 | Hepatic necrosis (HP:0002605) | 2.67463000 |
| 33 | Carpal bone hypoplasia (HP:0001498) | 2.67241395 |
| 34 | Cerebral hypomyelination (HP:0006808) | 2.61875085 |
| 35 | Entropion (HP:0000621) | 2.58573492 |
| 36 | Exercise intolerance (HP:0003546) | 2.55482431 |
| 37 | Microretrognathia (HP:0000308) | 2.53269367 |
| 38 | Absent thumb (HP:0009777) | 2.52288877 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46268522 |
| 40 | Patellar aplasia (HP:0006443) | 2.43105760 |
| 41 | Stenosis of the external auditory canal (HP:0000402) | 2.42591490 |
| 42 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.38232191 |
| 43 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.36369120 |
| 44 | Poikiloderma (HP:0001029) | 2.31747957 |
| 45 | Lactic acidosis (HP:0003128) | 2.31446734 |
| 46 | Abnormal trabecular bone morphology (HP:0100671) | 2.30814890 |
| 47 | Respiratory difficulties (HP:0002880) | 2.28970344 |
| 48 | IgM deficiency (HP:0002850) | 2.24284482 |
| 49 | Abnormality of the preputium (HP:0100587) | 2.22721883 |
| 50 | Abnormality of DNA repair (HP:0003254) | 2.21610116 |
| 51 | Lethargy (HP:0001254) | 2.21280054 |
| 52 | IgG deficiency (HP:0004315) | 2.20918823 |
| 53 | Irregular epiphyses (HP:0010582) | 2.19217401 |
| 54 | Colon cancer (HP:0003003) | 2.18849629 |
| 55 | Severe combined immunodeficiency (HP:0004430) | 2.18548246 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.17216541 |
| 57 | Abnormality of renal resorption (HP:0011038) | 2.15384767 |
| 58 | 11 pairs of ribs (HP:0000878) | 2.14624842 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.12504651 |
| 60 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11879383 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11864445 |
| 62 | Premature graying of hair (HP:0002216) | 2.11641591 |
| 63 | Leukodystrophy (HP:0002415) | 2.11579177 |
| 64 | Respiratory failure (HP:0002878) | 2.09793811 |
| 65 | Triphalangeal thumb (HP:0001199) | 2.08527108 |
| 66 | Methylmalonic aciduria (HP:0012120) | 2.08306963 |
| 67 | Hyperglycinemia (HP:0002154) | 2.07450288 |
| 68 | Sparse eyelashes (HP:0000653) | 2.06877300 |
| 69 | Cleft eyelid (HP:0000625) | 2.06672477 |
| 70 | Horseshoe kidney (HP:0000085) | 2.06274049 |
| 71 | Pancytopenia (HP:0001876) | 2.05528185 |
| 72 | Pancreatic cysts (HP:0001737) | 2.04643385 |
| 73 | Pancreatic fibrosis (HP:0100732) | 2.03898521 |
| 74 | Abnormality of glycolysis (HP:0004366) | 2.03722225 |
| 75 | Increased serum pyruvate (HP:0003542) | 2.03722225 |
| 76 | Optic disc pallor (HP:0000543) | 2.02432762 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 2.02345248 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 2.02345248 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.01550061 |
| 80 | Glycosuria (HP:0003076) | 2.01550061 |
| 81 | Chromsome breakage (HP:0040012) | 2.01213132 |
| 82 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98826987 |
| 83 | Trismus (HP:0000211) | 1.98140019 |
| 84 | Meckel diverticulum (HP:0002245) | 1.96895145 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.95708368 |
| 86 | Increased muscle lipid content (HP:0009058) | 1.94452872 |
| 87 | Combined immunodeficiency (HP:0005387) | 1.94092300 |
| 88 | Bone marrow hypocellularity (HP:0005528) | 1.93851904 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 1.93552187 |
| 90 | Thrombocytosis (HP:0001894) | 1.92527017 |
| 91 | Hypoplasia of the radius (HP:0002984) | 1.90884790 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.90678312 |
| 93 | Abnormality of the ileum (HP:0001549) | 1.89269786 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.88676150 |
| 95 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88676150 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.88564039 |
| 97 | Cellular immunodeficiency (HP:0005374) | 1.88218325 |
| 98 | True hermaphroditism (HP:0010459) | 1.88174921 |
| 99 | Methylmalonic acidemia (HP:0002912) | 1.87954789 |
| 100 | Cerebral edema (HP:0002181) | 1.87597911 |
| 101 | Abnormal biliary tract physiology (HP:0012439) | 1.85959193 |
| 102 | Bile duct proliferation (HP:0001408) | 1.85959193 |
| 103 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85945758 |
| 104 | Depressed nasal ridge (HP:0000457) | 1.85642707 |
| 105 | Secondary amenorrhea (HP:0000869) | 1.83663203 |
| 106 | Emotional lability (HP:0000712) | 1.83174869 |
| 107 | Abnormality of the axillary hair (HP:0100134) | 1.82474446 |
| 108 | Abnormality of secondary sexual hair (HP:0009888) | 1.82474446 |
| 109 | Multiple enchondromatosis (HP:0005701) | 1.82050166 |
| 110 | Absent radius (HP:0003974) | 1.80548036 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 1.80109381 |
| 112 | Abnormal glycosylation (HP:0012345) | 1.80109381 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80109381 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80109381 |
| 115 | B lymphocytopenia (HP:0010976) | 1.78671827 |
| 116 | Myelodysplasia (HP:0002863) | 1.77806703 |
| 117 | CNS demyelination (HP:0007305) | 1.76478774 |
| 118 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75904504 |
| 119 | Neutropenia (HP:0001875) | 1.74337140 |
| 120 | Abnormality of methionine metabolism (HP:0010901) | 1.73528422 |
| 121 | Abnormality of chromosome stability (HP:0003220) | 1.73233779 |
| 122 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.72841073 |
| 123 | Constricted visual fields (HP:0001133) | 1.72614868 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.69949744 |
| 125 | Duodenal stenosis (HP:0100867) | 1.69746201 |
| 126 | Small intestinal stenosis (HP:0012848) | 1.69746201 |
| 127 | Testicular atrophy (HP:0000029) | 1.69373579 |
| 128 | Facial cleft (HP:0002006) | 1.66530079 |
| 129 | Hyperalaninemia (HP:0003348) | 1.66305457 |
| 130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66305457 |
| 131 | Hyperphosphaturia (HP:0003109) | 1.64782823 |
| 132 | Attenuation of retinal blood vessels (HP:0007843) | 1.63438361 |
| 133 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.60134046 |
| 134 | Abnormality of B cell number (HP:0010975) | 1.59822632 |
| 135 | Progressive microcephaly (HP:0000253) | 1.59052566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.40071099 |
| 2 | BUB1 | 5.27037716 |
| 3 | NME2 | 4.65177013 |
| 4 | STK16 | 4.10653866 |
| 5 | WEE1 | 3.62477431 |
| 6 | EIF2AK1 | 3.31520347 |
| 7 | VRK1 | 2.72535143 |
| 8 | MAP4K2 | 2.57818259 |
| 9 | EIF2AK3 | 2.46521581 |
| 10 | BCKDK | 2.34712951 |
| 11 | INSRR | 2.30371460 |
| 12 | SRPK1 | 2.19913085 |
| 13 | PLK4 | 2.19554117 |
| 14 | NEK1 | 2.16373813 |
| 15 | NME1 | 2.05362921 |
| 16 | TESK2 | 1.91342665 |
| 17 | DYRK3 | 1.82762790 |
| 18 | BRSK2 | 1.77239204 |
| 19 | ACVR1B | 1.75675216 |
| 20 | TLK1 | 1.74584082 |
| 21 | MKNK1 | 1.71866698 |
| 22 | MKNK2 | 1.70563948 |
| 23 | CDK8 | 1.56662008 |
| 24 | PIM2 | 1.54936152 |
| 25 | CDC7 | 1.54733897 |
| 26 | TSSK6 | 1.53905559 |
| 27 | PLK1 | 1.47266864 |
| 28 | RPS6KB2 | 1.44226363 |
| 29 | NEK2 | 1.43011409 |
| 30 | TAOK3 | 1.42170151 |
| 31 | PLK3 | 1.40980286 |
| 32 | MST4 | 1.40167095 |
| 33 | MAP3K12 | 1.33778657 |
| 34 | TTK | 1.32414416 |
| 35 | TRIM28 | 1.25927116 |
| 36 | CDK7 | 1.25146066 |
| 37 | AURKB | 1.21010486 |
| 38 | BRAF | 1.18148808 |
| 39 | CCNB1 | 1.17792210 |
| 40 | AURKA | 1.15461247 |
| 41 | CHEK2 | 1.14342505 |
| 42 | IRAK3 | 1.11221985 |
| 43 | KDR | 1.07240594 |
| 44 | BRSK1 | 1.05102568 |
| 45 | RPS6KA4 | 1.03694674 |
| 46 | PDK2 | 1.02097338 |
| 47 | TAF1 | 1.00107461 |
| 48 | CDK3 | 0.98919778 |
| 49 | WNK3 | 0.98462285 |
| 50 | EIF2AK2 | 0.96992517 |
| 51 | NLK | 0.95379325 |
| 52 | ZAK | 0.95283085 |
| 53 | BMPR1B | 0.94958317 |
| 54 | DYRK2 | 0.93343096 |
| 55 | MAP4K1 | 0.93170881 |
| 56 | TXK | 0.93079026 |
| 57 | CDK19 | 0.90447049 |
| 58 | ATR | 0.87273658 |
| 59 | EPHA2 | 0.86954822 |
| 60 | MARK3 | 0.83707393 |
| 61 | PASK | 0.81354852 |
| 62 | MAP3K8 | 0.80283709 |
| 63 | CSNK1G3 | 0.79898228 |
| 64 | PBK | 0.79309954 |
| 65 | TEC | 0.76805706 |
| 66 | IRAK2 | 0.74693533 |
| 67 | IRAK4 | 0.74130516 |
| 68 | CSNK2A1 | 0.73977925 |
| 69 | PAK1 | 0.73357422 |
| 70 | CLK1 | 0.71769841 |
| 71 | LRRK2 | 0.71332313 |
| 72 | CSNK2A2 | 0.69429914 |
| 73 | TGFBR1 | 0.69045795 |
| 74 | GRK6 | 0.64538037 |
| 75 | PIM1 | 0.63777361 |
| 76 | CSNK1G1 | 0.63120352 |
| 77 | PRKCI | 0.60279347 |
| 78 | ADRBK2 | 0.59556775 |
| 79 | ILK | 0.58165634 |
| 80 | ARAF | 0.57198051 |
| 81 | MYLK | 0.56368608 |
| 82 | TESK1 | 0.56022210 |
| 83 | RPS6KA5 | 0.55580633 |
| 84 | IKBKB | 0.55339767 |
| 85 | GRK1 | 0.54812611 |
| 86 | PNCK | 0.54330673 |
| 87 | MUSK | 0.53444272 |
| 88 | ABL2 | 0.53034854 |
| 89 | ZAP70 | 0.52852430 |
| 90 | CDK4 | 0.51359731 |
| 91 | GRK7 | 0.50783243 |
| 92 | CHEK1 | 0.49628702 |
| 93 | STK10 | 0.49011298 |
| 94 | STK24 | 0.48236618 |
| 95 | PAK4 | 0.47904494 |
| 96 | CSNK1G2 | 0.47831302 |
| 97 | KIT | 0.46509792 |
| 98 | DAPK1 | 0.46360863 |
| 99 | AKT3 | 0.45830302 |
| 100 | MAP2K7 | 0.45450241 |
| 101 | CSNK1A1L | 0.45009875 |
| 102 | MAP2K2 | 0.44766111 |
| 103 | LATS1 | 0.44503308 |
| 104 | MAP3K11 | 0.44160351 |
| 105 | TNIK | 0.43802408 |
| 106 | MAP3K3 | 0.42959029 |
| 107 | MATK | 0.40416592 |
| 108 | PIK3CG | 0.40263742 |
| 109 | STK4 | 0.39714761 |
| 110 | NEK6 | 0.39485051 |
| 111 | SYK | 0.38502251 |
| 112 | LYN | 0.37941082 |
| 113 | DAPK3 | 0.37585797 |
| 114 | PINK1 | 0.34446537 |
| 115 | RAF1 | 0.33378947 |
| 116 | FES | 0.32447337 |
| 117 | NUAK1 | 0.31536193 |
| 118 | MAPK4 | 0.31313417 |
| 119 | SCYL2 | 0.31290630 |
| 120 | BTK | 0.31070951 |
| 121 | CASK | 0.30628161 |
| 122 | CDK2 | 0.30409976 |
| 123 | BMPR2 | 0.29657456 |
| 124 | ATM | 0.29287832 |
| 125 | MAPKAPK5 | 0.28699133 |
| 126 | MELK | 0.27605818 |
| 127 | FLT3 | 0.27449405 |
| 128 | PRKCQ | 0.27399170 |
| 129 | MAP3K5 | 0.26878642 |
| 130 | YES1 | 0.26429462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.76122737 |
| 2 | * RNA polymerase_Homo sapiens_hsa03020 | 4.34464363 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.19882613 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.56294077 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.41745755 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.34638379 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.97092117 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.72326765 |
| 9 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.72123318 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69204388 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.51536568 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.44321721 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35659501 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 2.35510801 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.20275523 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.19189930 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.02574716 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.81141882 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78454259 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.70733827 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.69669648 |
| 22 | * Purine metabolism_Homo sapiens_hsa00230 | 1.60663816 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53587729 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50049412 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.43561046 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39719758 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37960273 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36997609 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24726146 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12588057 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10686623 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06874489 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06607017 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02105448 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96020379 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95005641 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83886523 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81691583 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80585056 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77812471 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75262055 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74958736 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71943627 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69455503 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68827808 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68189247 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65058598 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65025332 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63210394 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.62749800 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62476717 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61223398 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60527717 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60066399 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59719679 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58396069 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56524658 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55259390 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.54652641 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52943836 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51792011 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51763870 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51343106 |
| 64 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50695006 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49869143 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49248342 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48307000 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45737024 |
| 69 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44102940 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42617031 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.42502279 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41060179 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40853345 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39624976 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38996375 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38047044 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36099284 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36078930 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35384971 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.33829941 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32421893 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31460023 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29836117 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28941853 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27714483 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26889971 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26394138 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26168151 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25732320 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25089725 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24659308 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24219898 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24136330 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23581057 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23565752 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22946505 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22353038 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21626779 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.20848062 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20847846 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20123344 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.16108071 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.15590753 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15583548 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13725072 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.13553386 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.13467447 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.12956699 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.12290153 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.11971336 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11201691 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10843862 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10096168 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.09594977 |
| 115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.09161673 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.07832377 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.07731538 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.06974019 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.06252430 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05952975 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.05362945 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04648735 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03204086 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.02979697 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.02335090 |

